A Medical Device Daily

Cook Biotech (West Lafayette, Indiana) reported that the U.S. Court of Appeals for the Federal Circuit denied its petition to reconsider the court’s earlier decision to overturn the verdict reached by a jury in the Federal Court for the Northern District of Indiana concerning biomaterials derived from bladder tissue for use as medical products.

Cook Biotech officials said in a statement that they “remain determined” to protect their patent rights to this technology.

The patent at issue is one in a portfolio of patents owned or licensed by Cook Biotech describing the rights to inventionsrelated to technology discovered at Purdue University (West Lafayette, Indiana) and numerous new medical products that Cook Biotech manufactures at its facility in the Purdue Research Park.

Mark Bleyer, president of Cook Biotech, said, “Issues regarding patents may seem complex, but resolving these matters is important since these patents describe the technology that we have paid for and invested in to bring products to patients. Our desire is to properly resolve these matters so we can continue to invest in this technology.

“In light of this latest development, Cook Biotech will review its options for correcting the appellate court’s decision and remains determined to uphold its rights to this important technology.”

Cook Biotech produces tissue-engineered biomaterials and manufactures extracellular matrix (ECM) technologies for medical purposes. It says that ECM biomaterials were discovered to have a unique scaffold structure and composition that supports tissue ingrowth, with potential uses for implants and grafts that reinforce or repair damaged or diseased tissue structures.

Cook Biotech was founded in 1995 with shared ownership by Cook Group, Purdue Research Foundation and Methodist Hospital/Clarian .